Acquisition of Syncom - Sole financial adviser Gilde Healthcare

Gilde Healthcare is a specialised European healthcare investor

Transaction highlights

  • Gilde Healthcare, together with Dutch pension service provider PGGM, as co-investor, have invested in Mercachem and Syncom, two of the leading European drug discovery Contract Research Organizations (CRO)
  • The resulting Mercachem-Syncom Group, with operations in Nijmegen and Groningen, the Netherlands and Prague, Czech Republic, becomes the premier European mid-sized CRO offering innovative best-in-class chemistry solutions
  • Kempen acted as adviser to Gilde Healthcare in the acquisition of Syncom

More information? Contact

Jan De Kerpel